APGE Q1 2023 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$142M

Total Liabilities

$11M

Stockholders' Equity

$131M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$13M	-$4M	-194.0%
Net Income	-$13M	-$4M	-190.9%